The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injectable Bone Substitute Market Research Report 2024
Synopsis
Injectable Bone Substitute is a kind of bone substitute used in orthopedic surgical procedure which replaces missing bone in order to repair bone fracture. It can be used through a special syringe.
The global Injectable Bone Substitute market was valued at US$ 210.5 million in 2023 and is anticipated to reach US$ 299.3 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
Injectable bone substitutes are biomaterials used in medical and orthopedic procedures to replace or enhance bone tissue. These replacements are commonly used for fracture repairs, vertebral fusion surgeries, joint replacements, and more. Following are some of the major driving factors impacting the injectable bone substitutes market:
1. Aging population: As the aging of the population accelerates, the risk of bone-related diseases and fractures is also increasing, thus driving the demand for injectable bone substitutes.
2. Increase in bone-related diseases: The incidence of bone-related diseases such as fractures, osteoporosis, and bone tumors is increasing, requiring more bone substitutes to support treatment and recovery.
In summary, the growth of the injectable bone substitutes market is driven by several factors such as aging population, increase in bone-related diseases, increase in orthopedic surgeries, and technological advancements. These alternatives play an important role in orthopedic care, providing patients with more treatment options.
This report aims to provide a comprehensive presentation of the global market for Injectable Bone Substitute, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Bone Substitute.
Report Scope
The Injectable Bone Substitute market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Bone Substitute market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Bone Substitute companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wright Medical
Zimmer Biomet
Medtronic
SeaSpine
DePuy Synthes
Stryker
Xtant Medical
Graftys
Arthrex
Biomatlante
Biocomposites
ORD
Anika Therapeutics, Inc
Bioceramed
Segment by Type
Natural
Synthetic
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Bone Substitute companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Injectable Bone Substitute is a kind of bone substitute used in orthopedic surgical procedure which replaces missing bone in order to repair bone fracture. It can be used through a special syringe.
The global Injectable Bone Substitute market was valued at US$ 210.5 million in 2023 and is anticipated to reach US$ 299.3 million by 2030, witnessing a CAGR of 4.7% during the forecast period 2024-2030.
Injectable bone substitutes are biomaterials used in medical and orthopedic procedures to replace or enhance bone tissue. These replacements are commonly used for fracture repairs, vertebral fusion surgeries, joint replacements, and more. Following are some of the major driving factors impacting the injectable bone substitutes market:
1. Aging population: As the aging of the population accelerates, the risk of bone-related diseases and fractures is also increasing, thus driving the demand for injectable bone substitutes.
2. Increase in bone-related diseases: The incidence of bone-related diseases such as fractures, osteoporosis, and bone tumors is increasing, requiring more bone substitutes to support treatment and recovery.
In summary, the growth of the injectable bone substitutes market is driven by several factors such as aging population, increase in bone-related diseases, increase in orthopedic surgeries, and technological advancements. These alternatives play an important role in orthopedic care, providing patients with more treatment options.
This report aims to provide a comprehensive presentation of the global market for Injectable Bone Substitute, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Bone Substitute.
Report Scope
The Injectable Bone Substitute market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Bone Substitute market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Bone Substitute companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Wright Medical
Zimmer Biomet
Medtronic
SeaSpine
DePuy Synthes
Stryker
Xtant Medical
Graftys
Arthrex
Biomatlante
Biocomposites
ORD
Anika Therapeutics, Inc
Bioceramed
Segment by Type
Natural
Synthetic
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Bone Substitute companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Bone Substitute Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Natural
1.2.3 Synthetic
1.3 Market by Application
1.3.1 Global Injectable Bone Substitute Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injectable Bone Substitute Market Perspective (2019-2030)
2.2 Injectable Bone Substitute Growth Trends by Region
2.2.1 Global Injectable Bone Substitute Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Injectable Bone Substitute Historic Market Size by Region (2019-2024)
2.2.3 Injectable Bone Substitute Forecasted Market Size by Region (2025-2030)
2.3 Injectable Bone Substitute Market Dynamics
2.3.1 Injectable Bone Substitute Industry Trends
2.3.2 Injectable Bone Substitute Market Drivers
2.3.3 Injectable Bone Substitute Market Challenges
2.3.4 Injectable Bone Substitute Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injectable Bone Substitute Players by Revenue
3.1.1 Global Top Injectable Bone Substitute Players by Revenue (2019-2024)
3.1.2 Global Injectable Bone Substitute Revenue Market Share by Players (2019-2024)
3.2 Global Injectable Bone Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injectable Bone Substitute Revenue
3.4 Global Injectable Bone Substitute Market Concentration Ratio
3.4.1 Global Injectable Bone Substitute Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Bone Substitute Revenue in 2023
3.5 Injectable Bone Substitute Key Players Head office and Area Served
3.6 Key Players Injectable Bone Substitute Product Solution and Service
3.7 Date of Enter into Injectable Bone Substitute Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injectable Bone Substitute Breakdown Data by Type
4.1 Global Injectable Bone Substitute Historic Market Size by Type (2019-2024)
4.2 Global Injectable Bone Substitute Forecasted Market Size by Type (2025-2030)
5 Injectable Bone Substitute Breakdown Data by Application
5.1 Global Injectable Bone Substitute Historic Market Size by Application (2019-2024)
5.2 Global Injectable Bone Substitute Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Injectable Bone Substitute Market Size (2019-2030)
6.2 North America Injectable Bone Substitute Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Injectable Bone Substitute Market Size by Country (2019-2024)
6.4 North America Injectable Bone Substitute Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injectable Bone Substitute Market Size (2019-2030)
7.2 Europe Injectable Bone Substitute Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Injectable Bone Substitute Market Size by Country (2019-2024)
7.4 Europe Injectable Bone Substitute Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injectable Bone Substitute Market Size (2019-2030)
8.2 Asia-Pacific Injectable Bone Substitute Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Injectable Bone Substitute Market Size by Region (2019-2024)
8.4 Asia-Pacific Injectable Bone Substitute Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injectable Bone Substitute Market Size (2019-2030)
9.2 Latin America Injectable Bone Substitute Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Injectable Bone Substitute Market Size by Country (2019-2024)
9.4 Latin America Injectable Bone Substitute Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injectable Bone Substitute Market Size (2019-2030)
10.2 Middle East & Africa Injectable Bone Substitute Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Injectable Bone Substitute Market Size by Country (2019-2024)
10.4 Middle East & Africa Injectable Bone Substitute Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Wright Medical
11.1.1 Wright Medical Company Detail
11.1.2 Wright Medical Business Overview
11.1.3 Wright Medical Injectable Bone Substitute Introduction
11.1.4 Wright Medical Revenue in Injectable Bone Substitute Business (2019-2024)
11.1.5 Wright Medical Recent Development
11.2 Zimmer Biomet
11.2.1 Zimmer Biomet Company Detail
11.2.2 Zimmer Biomet Business Overview
11.2.3 Zimmer Biomet Injectable Bone Substitute Introduction
11.2.4 Zimmer Biomet Revenue in Injectable Bone Substitute Business (2019-2024)
11.2.5 Zimmer Biomet Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Injectable Bone Substitute Introduction
11.3.4 Medtronic Revenue in Injectable Bone Substitute Business (2019-2024)
11.3.5 Medtronic Recent Development
11.4 SeaSpine
11.4.1 SeaSpine Company Detail
11.4.2 SeaSpine Business Overview
11.4.3 SeaSpine Injectable Bone Substitute Introduction
11.4.4 SeaSpine Revenue in Injectable Bone Substitute Business (2019-2024)
11.4.5 SeaSpine Recent Development
11.5 DePuy Synthes
11.5.1 DePuy Synthes Company Detail
11.5.2 DePuy Synthes Business Overview
11.5.3 DePuy Synthes Injectable Bone Substitute Introduction
11.5.4 DePuy Synthes Revenue in Injectable Bone Substitute Business (2019-2024)
11.5.5 DePuy Synthes Recent Development
11.6 Stryker
11.6.1 Stryker Company Detail
11.6.2 Stryker Business Overview
11.6.3 Stryker Injectable Bone Substitute Introduction
11.6.4 Stryker Revenue in Injectable Bone Substitute Business (2019-2024)
11.6.5 Stryker Recent Development
11.7 Xtant Medical
11.7.1 Xtant Medical Company Detail
11.7.2 Xtant Medical Business Overview
11.7.3 Xtant Medical Injectable Bone Substitute Introduction
11.7.4 Xtant Medical Revenue in Injectable Bone Substitute Business (2019-2024)
11.7.5 Xtant Medical Recent Development
11.8 Graftys
11.8.1 Graftys Company Detail
11.8.2 Graftys Business Overview
11.8.3 Graftys Injectable Bone Substitute Introduction
11.8.4 Graftys Revenue in Injectable Bone Substitute Business (2019-2024)
11.8.5 Graftys Recent Development
11.9 Arthrex
11.9.1 Arthrex Company Detail
11.9.2 Arthrex Business Overview
11.9.3 Arthrex Injectable Bone Substitute Introduction
11.9.4 Arthrex Revenue in Injectable Bone Substitute Business (2019-2024)
11.9.5 Arthrex Recent Development
11.10 Biomatlante
11.10.1 Biomatlante Company Detail
11.10.2 Biomatlante Business Overview
11.10.3 Biomatlante Injectable Bone Substitute Introduction
11.10.4 Biomatlante Revenue in Injectable Bone Substitute Business (2019-2024)
11.10.5 Biomatlante Recent Development
11.11 Biocomposites
11.11.1 Biocomposites Company Detail
11.11.2 Biocomposites Business Overview
11.11.3 Biocomposites Injectable Bone Substitute Introduction
11.11.4 Biocomposites Revenue in Injectable Bone Substitute Business (2019-2024)
11.11.5 Biocomposites Recent Development
11.12 ORD
11.12.1 ORD Company Detail
11.12.2 ORD Business Overview
11.12.3 ORD Injectable Bone Substitute Introduction
11.12.4 ORD Revenue in Injectable Bone Substitute Business (2019-2024)
11.12.5 ORD Recent Development
11.13 Anika Therapeutics, Inc
11.13.1 Anika Therapeutics, Inc Company Detail
11.13.2 Anika Therapeutics, Inc Business Overview
11.13.3 Anika Therapeutics, Inc Injectable Bone Substitute Introduction
11.13.4 Anika Therapeutics, Inc Revenue in Injectable Bone Substitute Business (2019-2024)
11.13.5 Anika Therapeutics, Inc Recent Development
11.14 Bioceramed
11.14.1 Bioceramed Company Detail
11.14.2 Bioceramed Business Overview
11.14.3 Bioceramed Injectable Bone Substitute Introduction
11.14.4 Bioceramed Revenue in Injectable Bone Substitute Business (2019-2024)
11.14.5 Bioceramed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
